Articles By Jonathan Weiss
The first homegrown Indian biologic drug, ALZUMAb, has hit the market in India for the treatment of moderate to severe plaque psoriasis. By looking at tens of thousands of women over decades, researchers have found that regularly consuming fish heavy in omega-3 fatty acids can reduce the incidence of rheumatoid arthritis significantly. Tivicay is a new integrase inhibitor made by GlaxoSmithKline which was shown to be slightly better than Gilead's Atripla in reducing viral load in HIV infected patients after 48 weeks. An experimental drug from Bristol-Meyers Squibb and Albany Molecular Research, code-named BMS-820836, was shown to have no more effectiveness in treating untreatable depression compared to drugs currently on the market.
5 Mental Disorders Linked To 1 Genetic Variation; Schizophrenia And Bipolar Disorder Share Closest Connection
Using powerful genetic tools and a large pool of participants, researchers have found one genetic mutation common among five mental disorders.
Michigan Doctor Accused Of $35M In Medicare Fraud: Farid Fata Deliberately Misdiagnosed Cancer For Over 2 Years
Michigan doctor Farid Fata falsely billed $35 million to Medicare after treating patients with chemotherapy even if they didn't have cancer. Cyclospora, a foodborne parasite, has sickened 500 individuals in the United States. As of now, no one has become a fatal case. Weeks after GlaxoSmithKline had four executives in China put in jail, Sanofi is being investigated for over a quarter-million dollars in bribes.
FDA Decision To Increase Charges To Pharmaceutical Companies For Generic Drug Reviews Is A Good Thing
Because of the significant cost in reviewing drug approval applications, the FDA is now charging generics makers more, but not that much more compared to drug developers who make brand name drugs.
Idan Zablocki, Baby Boy With Rare Immune Disorder, May Be Cured Thanks To The Generosity Of Strangers
Idan Zablocki was diagnosed with a rare genetic immune disorder that leaves him unable to fight off simple infections. As the Indian government revokes even more drug patents, such as those on Allergan's eye drugs, it sets a dangerous precedent for the lack of protection afforded to drug developers.